Nonoperating Income (Expense) in USD of BICYCLE THERAPEUTICS PLC from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bicycle Therapeutics Plc quarterly/annual Nonoperating Income (Expense) history and change rate from 2017 to Q3 2025.
  • Bicycle Therapeutics Plc Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $6.66M, a 30.6% decline year-over-year.
  • Bicycle Therapeutics Plc Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $37.2M, a 38.7% increase year-over-year.
  • Bicycle Therapeutics Plc annual Nonoperating Income (Expense) for 2024 was $36.1M, a 236% increase from 2023.
  • Bicycle Therapeutics Plc annual Nonoperating Income (Expense) for 2023 was $10.7M, a 345% increase from 2022.
  • Bicycle Therapeutics Plc annual Nonoperating Income (Expense) for 2022 was $2.41M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $37.2M $6.66M -$2.94M -30.6% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $40.1M $7.42M +$469K +6.75% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $39.6M $8.36M +$3.56M +74.1% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $36.1M $14.7M +$9.27M +170% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2025
Q3 2024 $26.8M $9.6M +$6.43M +203% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $20.4M $6.95M +$6.96M 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 $13.4M $4.8M +$2.68M +126% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $10.7M $5.46M +$3.64M +201% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 $7.1M $3.17M +$2M +170% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $5.1M -$9K -$34K -136% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $5.13M $2.12M +$2.72M 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $2.41M $1.81M +$2.58M 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025
Q3 2022 -$163K $1.17M +$1.97M 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 -$2.14M $25K +$821K 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 -$2.96M -$600K -$93K -18.3% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 -$2.86M -$762K -$333K -77.6% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 -$2.53M -$799K -$871K -1210% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 -$1.66M -$796K -$1.17M -315% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 -$493K -$507K -$719K -339% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $226K -$429K -$649K -295% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2021
Q3 2020 $875K $72K -$368K -83.6% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $1.24M $371K +$2.47M 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$1.22M $212K +$3.34M 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 -$4.56M $220K -$681K -75.6% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 -$3.88M $440K +$1.78M 01 Jul 2019 30 Sep 2019 10-K 11 Mar 2021
Q2 2019 -$5.66M -$2.09M -$2.07M -9871% 01 Apr 2019 30 Jun 2019 10-K 11 Mar 2021
Q1 2019 -$3.58M -$3.13M -$3.09M -7532% 01 Jan 2019 31 Mar 2019 10-K 11 Mar 2021
Q4 2018 -$496K $901K 01 Oct 2018 31 Dec 2018 10-K 10 Mar 2020
Q3 2018 -$1.34M 01 Jul 2018 30 Sep 2018 10-K 10 Mar 2020
Q2 2018 -$21K 01 Apr 2018 30 Jun 2018 10-K 10 Mar 2020
Q1 2018 -$41K 01 Jan 2018 31 Mar 2018 10-K 10 Mar 2020

BICYCLE THERAPEUTICS PLC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $36.1M +$25.3M +236% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2025
2023 $10.7M +$8.33M +345% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025
2022 $2.41M +$5.28M 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025
2021 -$2.86M -$3.09M -1367% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 $226K +$4.79M 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 -$4.56M -$4.07M -820% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 -$496K -$427K -619% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021
2017 -$69K 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.